DAVID POPLACK to Time Factors
This is a "connection" page, showing publications DAVID POPLACK has written about Time Factors.
Connection Strength
0.143
-
Variability in the oral bioavailability of all-trans-retinoic acid. J Natl Cancer Inst. 1993 Jun 16; 85(12):993-6.
Score: 0.013
-
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion. Cancer Res. 1993 Mar 01; 53(5):1032-6.
Score: 0.013
-
Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein. Cancer Res. 1993 Feb 01; 53(3):472-6.
Score: 0.013
-
Dose-dependent pharmacokinetics of all-trans-retinoic acid. J Natl Cancer Inst. 1992 Sep 02; 84(17):1332-5.
Score: 0.012
-
The child with recurrent solid tumor. Pediatr Clin North Am. 1991 Apr; 38(2):489-504.
Score: 0.011
-
A rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid. Lab Anim Sci. 1990 Sep; 40(5):520-5.
Score: 0.011
-
Kinetic model for disposition of 6-mercaptopurine in monkey plasma and cerebrospinal fluid. Am J Physiol. 1985 Feb; 248(2 Pt 2):R147-56.
Score: 0.007
-
Plasma and cerebrospinal fluid pharmacokinetics of recombinant interferon alpha A in monkeys: comparison of intravenous, intramuscular, and intraventricular delivery. Cancer Drug Deliv. 1985; 2(4):247-53.
Score: 0.007
-
L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Res. 1981 Nov; 41(11 Pt 1):4554-8.
Score: 0.006
-
Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia. Cancer Res. 1981 Nov; 41(11 Pt 1):4508-11.
Score: 0.006
-
Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen. Cancer Treat Rep. 1981; 65 Suppl 4:93-6.
Score: 0.006
-
Ability of a new antitumor agent, AZQ, to penetrate into cerebrospinal fluid. Pharmacology. 1981; 22(3):196-8.
Score: 0.006
-
Adrenal suppression after short-term corticosteroid therapy. Lancet. 1979 Mar 24; 1(8117):630-3.
Score: 0.005
-
Acute encephalopathy after initiation of cranial irradiation for meningeal leukaemia. Lancet. 1978 Jul 01; 2(8079):13-5.
Score: 0.005
-
The effect of Mycobacterium bovis (Bacillus Calmette-Gu?rin) on macrophage random migration, chemotaxis, and pinocytosis. Cancer Res. 1976 Apr; 36(4):1233-7.
Score: 0.004
-
Intrathecal administration of topotecan in nonhuman primates. Cancer Chemother Pharmacol. 1995; 36(2):121-4.
Score: 0.004
-
Effect of body position on ventricular CSF methotrexate concentration following intralumbar administration. J Clin Oncol. 1995 Jan; 13(1):177-9.
Score: 0.004
-
The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia. Leuk Res. 1994 Nov; 18(11):805-10.
Score: 0.004
-
Transient acute hepatotoxicity of high-dose methotrexate therapy during childhood. NCI Monogr. 1987; (5):207-12.
Score: 0.002
-
Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med. 1981 May 07; 304(19):1121-4.
Score: 0.001
-
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med. 1979 Aug; 67(2):194-200.
Score: 0.001
-
Combined modality treatment of Burkitt's lymphoma. Cancer Treat Rep. 1978 Dec; 62(12):2031-4.
Score: 0.001
-
"Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood. 1978 May; 51(5):835-42.
Score: 0.001
-
Prolonged granulocytopenia from incompatible platelet transfusions. N Engl J Med. 1974 May 30; 290(22):1220-3.
Score: 0.001